Skeletal muscle antigens have been reported as potential autoantibody targets in TAMG [34], and incomplete autoantigens, proteins cross-reacting with AChR, titin, and ryanodine receptor epitopes have also been demonstrated in MG [10, 35–37]. This evidence concerns the gene TTN and myasthenia gravis.